Thirty Madison
Published in

Thirty Madison

Minding the gap in women’s specialty healthcare

Announcing the merger of Thirty Madison and Nurx

Michelle Carnahan

Since we announced our plan to merge with Nurx last week, my excitement has only grown about what this partnership can mean for specialty healthcare. I‘ve spent thirty years in the healthcare industry; my career has been oriented toward finding gaps in care and trying to solve them. I’ve worked on diabetes medications, novel biotech for diagnosis, and, at Thirty Madison, directly expanding access to care for chronic conditions that affect millions, including gastrointestinal conditions, migraine, and allergic rhinitis. The journey in digital healthcare has been exciting. However, as a woman, I’ve been looking forward to the day we could add women’s healthcare to the list of specialty conditions we treat. Soon, upon the completion of the merger, we will do just that.

Managing and improving women’s health, especially given the real disparities that exist, is an equity issue. Women have a higher rate of depression, Black women are disproportionately affected by cardiovascular disease and anemia, and women are more likely to be disabled than men during their lifetime. We need to and can do better.

(Here I want to note that I’m talking about women and using the phrase “women’s health” with an eye to Halle Tecco and Julia Cheek’s recent blog post; the term should encompass health beyond reproductive health, as well as include those who are transgender and non-binary, while acknowledging that transgender and non-binary individuals suffer their own health disparities, including a greater overall risk for poor health.)

Tackling all of these disparities requires system-wide change. Our merger with Nurx will allow us to take on a small corner of improving women’s health. Our integrated care model at Thirty Madison delivers highly personalized care to those who need it, and we’re driving access and affordability through innovative partnerships in healthcare.

Tackling all of these disparities requires system-wide change. But our merger with Nurx will allow us to take on a small corner of improving women’s health.

Because women are disproportionately affected by gaps in care, I’m particularly excited about how our partnership with Nurx will accelerate our ability to look for and address gaps in specialty care. No one who has interacted with the traditional healthcare system for long is impressed by how it works; it’s fragmented and confusing, placing the burden on the patient to coordinate across doctors. Thirty Madison seeks to bridge those challenges to improve outcomes for patients.

In other words, our focus is on meaningfully impacting patient outcomes, particularly in areas that have been ignored for too long.

Combining our two companies will bring together proven approaches to conditions as diverse as allergic rhinitis, migraine, and rosacea; preventative treatments including birth control and PrEP; and diagnostics for COVID-19, HPV, and STIs. Bringing together our care models and our amazing teams, we look forward to expanding our approach to conditions across the acuity spectrum.

Our companies have grown in partnership with our patients, listening to patient experiences and iterating on traditional healthcare. By merging, we will have more insight into patient wants and needs, more information about how patients experience their healthcare journeys, and greater ability to improve patient outcomes.

One of our core values is Access for All — and this merger brings us a little closer to achieving it.



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Thirty Madison

Thirty Madison

The human-first health company bringing specialized care and treatment to everyone. Check us out at